Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1
2011 StandoutNobel
Myeloproliferative disorders: complications, survival and causes of death
2000
CD10 Expression in Primary Intestinal Large B-Cell Lymphomas
2002
MCM proteins and DNA replication
2006
Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells
2003
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
The history of cancer epigenetics
2004 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
2010
Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria
2000
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
2001
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Amphotericin B Nephrotoxicity in Children
2004
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996
Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant Bacteria
1999
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
HSP90 and the chaperoning of cancer
2005 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
The biochemistry of apoptosis
2000 StandoutNature
Primary Cutaneous Diffuse Large B-Cell Lymphoma
2002
Molecular mechanisms of cisplatin resistance
2011 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Utility of positron emission tomography scans in mantle cell lymphoma
2011
Hematopoietic growth factors in cancer patients with invasive fungal infections
1997
Prevalence and clinical significance of anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in patients with non‐Hodgkin's lymphoma
2002
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
2002
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
2007
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group
2010
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Malignant Gliomas in Adults
2008 Standout
Apoptosis
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
How were new medicines discovered?
2011 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
The predictive value of body protein for chemotherapy-induced toxicity
2000
Molecular signals in anti-apoptotic survival pathways
2001
Complement
2001 Standout
Prevention of Venous Thromboembolism
2008 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
2000
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
The colony-stimulating factors and cancer
2010
Neutrophils in cancer: neutral no more
2016 Standout
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
2005
Escaping Cell Death: Survival Proteins in Cancer
1999
Amphotericin B: 30 Years of Clinical Experience
1990
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
1996
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?
1998
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
2008 Standout
Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas
1999
Heat shock proteins – modulators of apoptosis in tumour cells
2000
Cytokines as therapy for opportunistic fungal infections
1998
The Evolution of B Precursor Leukemia in the Eμ-ret Mouse
1998
Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria
1996
Magnesium in Man: Implications for Health and Disease
2014 Standout
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
2007
Zygomycetes in Human Disease
2000 Standout
G-CSF and GM-CSF in Neutropenia
2015
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study
2003
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.
2002
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
2011
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
Aspergillus fumigatusand Aspergillosis
1999 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor
2007 StandoutNobel
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins
2008 StandoutNobel
Heat Shock Protein 27 Protects L929 Cells from Cisplatin-Induced Apoptosis by Enhancing Akt Activation and Abating Suppression of Thioredoxin Reductase Activity
2007
Works of P. Meusers being referenced
Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias
1988
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
2005
In Acute Myeloid Leukemia only the Coexpression of at Least Two Proteins Including P-Glycoprotein, the Multidrug Resistance-Related Protein MRP, bcl-2, Mutant p53 and Heat-Shock Protein 27 is Predictive for the Response to Induction Chemotherapy
1998
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
2000
Infection by <i>Alcaligenes xylosoxidans</i> subsp. <i>xylosoxidans</i> in Neutropenic Patients
1996
Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome
2004
Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance
1995
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas [see comments]
1993
Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine
1991
Amphotericin-b nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline
1987
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
1997
Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.
1997
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
2008